Doloff, J. C., Chen, C., & Waxman, D. J. (2014). Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2. BioMed Central.
استشهاد بنمط شيكاغوDoloff, Joshua C., Chong-Sheng Chen, و David J. Waxman. Anti-tumor Innate Immunity Activated By Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved By Anti-angiogenic Drugs That Spare VEGF Receptor 2. BioMed Central, 2014.
MLA استشهادDoloff, Joshua C., Chong-Sheng Chen, و David J. Waxman. Anti-tumor Innate Immunity Activated By Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved By Anti-angiogenic Drugs That Spare VEGF Receptor 2. BioMed Central, 2014.